4//SEC Filing
Beetham Thomas W. 4
Accession 0001179110-21-003728
CIK 0001730430other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 5:32 PM ET
Size
7.9 KB
Accession
0001179110-21-003728
Insider Transaction Report
Form 4
Beetham Thomas W.
Chief Legal Officer10% Owner
Transactions
- Award
Restricted Share Units
2021-03-20+5,855→ 5,855 total→ Class A Common Shares (5,855 underlying) - Award
Restricted Share Units
2021-03-20+4,287→ 4,287 total→ Class A Common Shares (4,287 underlying)
Footnotes (3)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
- [F2]The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.
- [F3]The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001741382
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 5:32 PM ET
- Size
- 7.9 KB